Pharmaceuticals Wuxi STA Inaugurates High Potency Oral Drug Product Manufacturing Facility

Source: Press release Wuxi STA

Related Vendors

Wuxi STA has recently developed its first high potency oral drug product manufacturing facility in China. With this project, the company aims to expand its integrated drug product R&D and manufacturing services to customers across the globe.

Tableting equipment in the high potency oral drug product manufacturing facility in Wuxi city, China.
Tableting equipment in the high potency oral drug product manufacturing facility in Wuxi city, China.
(Source: Wuxi STA)

Shanghai/China – Wuxi STA announced the opening of its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus. This new facility marks a milestone for Wuxi STA, further extending its drug product capacity and capabilities to meet the growing demand for HP drug candidate development and manufacturing services.

With this new facility, Wuxi STA is well positioned to provide an integrated R&D and manufacturing network for high potency active pharmaceutical ingredients (HPAPI) and drug product from preclinical to commercial manufacturing. Specifically, this facility will complement the services and offerings of Wuxi STA's existing HPAPI facilities in Changzhou and Shanghai Jinshan, which are near Wuxi city. Furthermore, Wuxi STA is slated to open a new HP sterile parenteral production plant in Q3, 2023 at the WuXi campus.

The containment performance target (CPT) of this new HP oral drug manufacturing facility meets the control requirements of occupational exposure limit (OEL) as low as nanogram per cubic meter level. The facility offers multiple formulation processes, including wet and dry granulation, tablet compression and coating, as well as capsule filling, with an annual production capacity of 400 million tablets and 200 million capsules.

(ID:48610611)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent